BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10022840)

  • 1. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
    Brass AL; Zhu AQ; Singh H
    EMBO J; 1999 Feb; 18(4):977-91. PubMed ID: 10022840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.
    Brass AL; Kehrli E; Eisenbeis CF; Storb U; Singh H
    Genes Dev; 1996 Sep; 10(18):2335-47. PubMed ID: 8824592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
    Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
    Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
    Eisenbeis CF; Singh H; Storb U
    Genes Dev; 1995 Jun; 9(11):1377-87. PubMed ID: 7797077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-step mechanism for recruitment of Pip by PU.1.
    Perkel JM; Atchison ML
    J Immunol; 1998 Jan; 160(1):241-52. PubMed ID: 9551977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions.
    Ortiz MA; Light J; Maki RA; Assa-Munt N
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2740-5. PubMed ID: 10077581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus.
    Carlsson R; Persson C; Leanderson T
    Mol Immunol; 2003 Jun; 39(16):1035-43. PubMed ID: 12749910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
    Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
    Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.
    O'Reilly D; Quinn CM; El-Shanawany T; Gordon S; Greaves DR
    J Biol Chem; 2003 Jun; 278(24):21909-19. PubMed ID: 12676954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pT alpha promoter and enhancer are direct targets for transactivation by E box-binding proteins.
    Petersson K; Ivars F; Sigvardsson M
    Eur J Immunol; 2002 Mar; 32(3):911-20. PubMed ID: 11870636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
    Marecki S; Atchison ML; Fenton MJ
    J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
    Su GH; Ip HS; Cobb BS; Lu MM; Chen HM; Simon MC
    J Exp Med; 1996 Jul; 184(1):203-14. PubMed ID: 8691135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mef2 proteins, required for muscle differentiation, bind an essential site in the Ig lambda enhancer.
    Satyaraj E; Storb U
    J Immunol; 1998 Nov; 161(9):4795-802. PubMed ID: 9794411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of PU.1/IRF-4/DNA ternary complex.
    Escalante CR; Brass AL; Pongubala JM; Shatova E; Shen L; Singh H; Aggarwal AK
    Mol Cell; 2002 Nov; 10(5):1097-105. PubMed ID: 12453417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains.
    Nagulapalli S; Atchison ML
    Mol Cell Biol; 1998 Aug; 18(8):4639-50. PubMed ID: 9671474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52.
    Mamane Y; Sharma S; Petropoulos L; Lin R; Hiscott J
    Immunity; 2000 Feb; 12(2):129-40. PubMed ID: 10714679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of IRF-4 in transcriptional regulation.
    Marecki S; Fenton MJ
    J Interferon Cytokine Res; 2002 Jan; 22(1):121-33. PubMed ID: 11846983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative hydroxyl radical footprinting reveals cooperative interactions between DNA-binding subdomains of PU.1 and IRF4.
    Gross P; Yee AA; Arrowsmith CH; Macgregor RB
    Biochemistry; 1998 Jul; 37(27):9802-11. PubMed ID: 9657694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1/Interferon Regulatory Factor interactions: mechanisms of transcriptional regulation.
    Marecki S; Fenton MJ
    Cell Biochem Biophys; 2000; 33(2):127-48. PubMed ID: 11325034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a monopartite sequence in PU.1 essential for nuclear import, DNA-binding and transcription of myeloid-specific genes.
    Kwok JC; Perdomo J; Chong BH
    J Cell Biochem; 2007 Aug; 101(6):1456-74. PubMed ID: 17340619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.